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 Abstract 
  Background:  The majority of haemodialysis (HD) patients gain weight between dialysis sessions 
and thereby become volume overloaded, whereas peritoneal dialysis (PD) is a more continuous 
technique. Cardiovascular mortality and hypertension is increased with both treatment modali-
ties. We therefore wished to compare volume status in PD and HD to determine whether PD pa-
tients are chronically volume overloaded, as a risk factor for cardiovascular mortality.  Study De-
sign, Setting and Participants:     We retrospectively audited 72 healthy HD patients and 115 
healthy PD patients attending a university hospital dialysis centre for routine outpatient treat-
ment, who had multi-frequency bioimpedance measurements of extracellular water to total 
body water (ECW/TBW).  Results:  The groups were well matched for age, sex, weight and ethnic-
ity, PD patients had greater urine output [1,075 (485–1,613) vs. 42.5 (0–1,020) ml/day, p   !   0.001], 
but there was no difference in antihypertensive prescription (63.5 vs. 76.4%), mean arterial blood 
pressure (post-dialysis 101.6   8   1.5 mm Hg vs. pre-dialysis 102   8   2.4 mm Hg), although post-di-
alysis arterial blood pressure was lower than in PD patients (96.4   8   3.1 mm Hg, p   !   0.05). The 
ratio of ECW/TBW fell after HD (pre-dialysis 0.394   8   0.001 vs. post-dialysis 0.389   8   0.004, p   !  
0.001) and was similar in the PD group to the group before HD (0.393   8   0.001), and greater than 
that in the group after HD (p   !   0.001). ECW/TBW was greater than the normal reference range in 
30% PD patients, 28% patients before HD and 20% patients after HD.   Conclusions:   Overhydra-
tion is common in healthy stable PD outpatients, and ECW volumes in PD patients are not dis-
similar to those of pre-dialysis HD patients. The role of chronic volume overload as a risk factor 
for cardiovascular disease needs further investigation.    Copyright © 2012 S. Karger AG, Basel 
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 Introduction 
  Despite the many technological advances in both haemodialysis and peritoneal dialysis 
over the years   [1, 2]  , the mortality of chronic kidney disease patients treated by dialysis 
(CKD5d) remains disappointingly high, with some studies reporting 5-year survival rates 
similar to those of patients with solid organ malignancies   [3, 4]  . Although CKD5d patient 
mortality varies between countries, mortality rates do appear to be falling   [5]  . 
    Haemodialysis and peritoneal dialysis treatments differ fundamentally in terms of one 
being an intermittent therapy, with marked changes in volume status and fluctuating blood 
pressure, whereas the other modality is continuous. Despite these differences, mortality is 
similar with both modalities   [6]  , with only a few reports suggesting a marginal benefit for 
those patients choosing peritoneal dialysis  [7] . As with haemodialysis, cardiovascular disease 
remains the commonest cause of death for peritoneal dialysis patients   [8]  . 
    Although there are many potential cardiovascular risk factors for the dialysis patient, 
including both conventional (including smoking, hypertension, diabetes mellitus, hypercho-
lesterolaemia and left ventricular hypertrophy) and CKD-specific risk factors (including 
anaemia, hyperphosphataemia and hyperhomocysteinaemia), there has been recent interest 
in the role of hypervolaemia as a cardiovascular risk factor   [9]  . Haemodialysis patients ac-
cumulate fluid between dialysis sessions, and more recently with the introduction of bio-
impedance assessments it is now recognised that peritoneal dialysis patients may also be 
volume overloaded  [10, 11] . We therefore decided to audit volume status in haemodialysis and 
peritoneal dialysis patients attending our university hospital dialysis centre, to compare vol-
ume status in these two groups.
  Patients  and  Methods 
  We studied 72 healthy adult haemodialysis patients attending our university hospital 
outpatient haemodialysis units for thrice weekly haemodialysis treatments, using high-flux 
haemodialysers, and 115 healthy peritoneal dialysis patients attending for routine outpatient 
assessment, with 33% prescribed hypertonic glucose exchanges (22.7 g/l glucose) and   1 95% 
icodextrin. All patients had bioimpedance assessments, these were made prior to the mid-
week dialysis session and then 20 min after dialysis for the haemodialysis cohort to allow for 
re-equilibration   [12]  , and following a standard peritoneal equilibrium test for the peritoneal 
dialysis group   [13]  . As such, pregnant patients, those with amputations and cardiac pace-
makers or defibrillators were excluded from the study as bioimpedance measurements were 
not made. Volume and body composition measurements were made using a direct multi-
frequency bioelectrical impedance (MF-BIA) analysis method using an eight hand and feet 
tactile electrode system (Biospace in body 720, Seoul, South Korea)   [14]  . Height was mea-
sured by a standard wall mounted measure (Sigmeas 1, Doherty signature range, www.medi-
click.co.uk).
    Serum biochemistry samples were analysed with a standard multi-channel biochemical 
analyser (Roche Integra, Roche Diagnostics, Lewes, UK), using the bromcresol green meth-
od for albumin determination; N-terminal pro-brain natriuretic peptide (NT-proBNP) was 
measured by immunoassay (ECLIA Roche Diagnostics, GMBH, Mannheim, Germany) and 
NT-proBNP samples were taken after the midweek dialysis session   [15]  . 24-hour urine col-
lections were analysed to determine urine volume and sodium content. Routine chest X-rays 
and standard two-dimensional transthoracic echocardiograms (Philips IE33, Philips Medi-
cal Systems, The Netherlands, www.healthcare.philips.com) were reviewed.50
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  Ethical approval was granted by the local ethical committee as audit and clinical service 
development.
  Statistical  Analysis 
 Statistical analysis was by Student’s t test for normally distributed data and Mann-Whit-
ney U test for nonparametric data (GraphPad Prism version 4.0, San Diego, Calif., USA). In 
addition     2   analysis with correction for small numbers and analysis of variance with post-
analysis correction were also performed using SPSS software for Windows version 15.0 (SPSS 
Inc., Chicago, Ill., USA). Data are expressed as mean   8   SE, median and interquartile range, 
or percentages. Statistical significance was taken at or below the 5% level.
  R e s u l t s  
  There was no difference in age between the haemodialysis cohort (55.0   8   0.0 years) 
and the peritoneal dialysis cohort (55.4   8   1.4 years), or sex distribution (50% male vs. 
44.4% male, respectively). However, there were more diabetics in the haemodialysis cohort 
(36.1 vs. 20%;     2   5.14, p = 0.023), and more patients were prescribed insulin (20.8 vs. 9.1%; 
    2   4.61, p = 0.31). However, there were no differences in dialysis vintage [median 22 (4.5–
39) vs. 25 (3–43) months], or race (54.2 vs. 57.4% Caucasoids). As expected the haemodi-
alysis patients had weight reduction with dialysis, but there was no difference in weight 
compared to the peritoneal dialysis cohort (  table 1  ). Body composition was similar in the 
two groups (  table 1  ). Urine output was greater in the peritoneal dialysis group [median 
1,075 (485–1,613) vs. 42.5 (0–1,010) ml/day, p  !  0.001], as was urinary sodium excretion [57 
(13–99) vs. 0 (0–61) mmol/day, p   !   0.001], and more were prescribed diuretics (77.4 vs. 
38.9%;     2   4.95, p = 0.026). However, similar numbers were prescribed anti-hypertensives 
Table 1.   Peritoneal dialysis patients before haemodialysis and a minimum of 20 min after haemodialysis 
to allow for redistribution
PD pre-HD post-HD
Patients, n 115 72 72
Weight, kg 70.181.4 68.881.7 66.981.7
BMI 25.780.4 25.380.7 24.780.7
BSA, m2 1.7780.02 1.7480.03 1.7280.03
SBP, mm Hg 140.782.3 147.283.3 138.083.0
DBP, mm Hg 81.881.4 79.480.4 75.680.3**
MAP, mm Hg 101.681.5 102.182.4 96.482.1*
ICW, l/1.73 m2 20.9280.27 21.6480.37 21.0580.39*
ECW, l/1.73 m2 13.6880.19 14.0480.23 13.2180.21
ECW/TBW 0.39380.001 0.39480.001 0.38980.004***
Fat mass, kg 21.980.9 19.581.3
Skeletal muscle mass, kg 26.180.6 25.680.8
Body fat, % 30.680.9 26.581.5
Waist:hip ratio 0.9480.01 0.9580.01
P  D = Peritoneal dialysis patients; HD = haemodialysis patients; BMI = body mass index; BSA = body 
surface area; SBP = systolic blood pressure; DBP = diastolic blood pressure; MAP = mean arterial blood 
pressure; ICW = intracellular water; ECW = extracellular water. * p < 0.05 vs. PD; ** p < 0.01 vs. PD;
*** p < 0.001 vs. PD.51
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(63.5 vs. 76.4%), and the median number of anti-hypertensives prescribed was not different 
[1 (0–2) vs. 1 (1–2)]. 
  J u s t   1 30% of the peritoneal dialysis group had a ratio of extracellular water to total body 
water (ECW/TBW) above the normal reference range of 0.36–0.40, which was similar to the 
pre-haemodialysis cohort (  fig. 1  ). The ECW/TBW ratios were higher in the peritoneal dialy-
sis group compared to those after haemodialysis (  table 1  ). Serum sodium was lower in the 
peritoneal dialysis group, and C-reactive protein higher in the haemodialysis cohort, with 
just under half the haemodialysis cohort dialysing with central venous access catheters. NT-
proBNP levels (  table 2  ), cardiac dimensions on chest X-ray and transthoracic echocardiog-
raphy were not different (  table 3  ).
  Discussion 
 It is readily accepted that the majority of patients attending for outpatient haemodialysis 
are volume overloaded and require ultrafiltration during a haemodialysis session. In our 
study of asymptomatic stable peritoneal dialysis patients attending for routine assessments 
of peritoneal dialysis adequacy and transport status (who were not thought to be clinically 
volume overloaded), volume status assessed by MF-BIA was similar to that of patients prior 
to haemodialysis, supporting earlier smaller studies   [16]  . Thus, despite greater urine output 
  Fig. 1.   ECW/TBW ratio in haemodialysis (HD) pa-
tients attending for midweek haemodialysis session 
(pre- and post-HD values), and peritoneal dialysis 
(PD) patients with peritoneal dialysate drained out. 
  *  p   !   0.05;   *  *  p   !   0.01 vs. PD patients. 
Table 2.   Peritoneal dialysis patients before and after haemodialysis
PD pre-HD post-HD
Sodium, mmol/l 13880.3 139.880.35*** 140.780.23***
Calcium, mmol/l 2.2980.02 2.2880.04 2.1580.02**
Glucose, mmol/l 6.480.3 7.681.0 6.880.2
Albumin, g/l 39.780.9 40.580.5 43.680.7**
CRP, mg/l 3 (1–10) 5 (2–13)*
PTH, pmol/l 23.4 (13.8–40.3) 20.2 (8.8–44.6)
NT-proBNP, pmol/l 242 (90–688) 251 (118–606)
P  D = Peritoneal dialysis patients; HD = haemodialysis patients; Calcium = corrected serum calcium; 
CRP = C-reactive protein; PTH = parathyroid hormone. * p < 0.05 vs. PD; ** p < 0.01 vs. PD; *** p < 0.001 
vs. PD.52
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and urinary sodium excretion peritoneal dialysis patients are similarly volume overloaded 
as haemodialysis patients.
    The results of MF-BIA depend upon the resistance and reactance to the passage of an 
electrical current, and our MF-BIA device has been validated in both healthy controls   [17, 
18]  and haemodialysis  [14]  and peritoneal dialysis patients  [19] . MF-BIA is affected by body 
composition which changes with age, sex and race   [20]  , and as such it has been suggested 
that volumes should be corrected for height  [21]  or body surface area  [22] . Volume overload 
in incident peritoneal dialysis patients is known to adversely determine outcome; however, 
it is not generally recognised that peritoneal dialysis patients are chronically volume over-
loaded  [23] . However, we did not find any differences in ECW, or when corrected for height 
or body surface area with the haemodialysis group, either before or after haemodialysis. 
Other reports have reported that ECW is greater in peritoneal dialysis patients compared 
to after dialysis   [24]  . This was a smaller study of predominantly Caucasoid patients with 
fewer diabetics. However, an increased ECW/TBW ratio can also be caused by a reduction 
in TBW due to a loss of intracellular water (ICW). Nearly all our peritoneal dialysis patients 
used icodextrin, which can increase plasma osmolality   [25]  , due to the accumulation of 
metabolites   [26]  , and could therefore potentially lead to water removal from and reduction 
in ICW. Another possible cause of a reduction is ICW protein energy malnutrition   [27]  . 
However, in our study both NT-proBNP values, a marker of extracellular volume expansion 
  [15]  , and ECHO cardiography dimensions were not different between the peritoneal and 
haemodialysis groups, in keeping with the changes in ECW/TBW which were due to ECW 
expansion, and not ICW loss. This is supported by body composition which was similar 
between the groups in terms of skeletal muscle and fat mass. As such, the ECW/TBW in 
the peritoneal dialysis patients cannot be explained by a loss of ICW and supports ECW 
expansion. 
    The lower serum albumin and sodium in the peritoneal dialysis group could be due to 
volume overload and dilution, and one previous study showed that serum albumin concen-
trations increased following deliberate ultrafiltration  [28] . The lower sodium, however, could 
also be an artefact of laboratory error   [29]   due to the usage of icodextrin   [26, 30]  . 
PD HD
CTR 0.4780.007 0.4980.008
LVEDD, cm 4.6980.07 4.5580.08
LVES, cm 3.0880.07 3.1580.1
IVSD, cm 1.280.02 1.280.02
PWD, cm 1.1380.12 1.1480.02
LASD, cm 4.080.14 3.9580.09
Ejection fraction, % 57.780.9 56.281.3
RVSP, mm Hg 25.981.4 27.781.2
Diastolic dysfunction 1 (1–1) 1 (0–1)
Systolic dysfunction 0 (0–0) 1 (0–1)
PD = Peritoneal dialysis patients; HD = haemodialysis pa-
tients; CTR = cardiothoracic ratio from departmental chest X-ray; 
LVEDD = left ventricular end-diastolic diameter; LVES = left ven-
tricular end-systolic diameter; IVSD = intraventricular septal diam-
eter; PWD = posterior wall diameter; LASD = left atrial end-systolic 
diameter; RVSP = estimated right ventricular end-systolic pressure; 
Diastolic/Systolic dysfunction = left ventricular diastolic and systolic 
dysfunction. 
  Ta b l e   3 .   Transthoracic 
echocardiographic 
examinations of haemodialysis 
and peritoneal dialysis patients   53
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  As expected, blood pressure fell after haemodialysis  [31] , but pre-dialysis blood pressure 
was not different compared to the peritoneal dialysis cohort. However, both post-dialysis 
mean arterial pressure and diastolic blood pressure were lower than those in the peritoneal 
dialysis group. Both groups had similar antihypertensive medication prescription, although 
more peritoneal dialysis patients were prescribed loop diuretics, reflecting greater urine vol-
umes. In keeping with blood pressure, transthoracic echocardiography assessments of car-
diac size were similar between the groups, as were NT-proBNP levels. It could be speculated 
that as NT-proBNP is degraded by the kidney, then levels should have been lower in the peri-
toneal dialysis group due to better residual renal function.
    After peritonitis   [32]  , ultrafiltration failure and clinically apparent volume overload are 
the next most common causes of peritoneal dialysis technique failure   [33]  . Our study shows 
that stable asymptomatic peritoneal dialysis patients are equally volume overloaded when 
compared to haemodialysis patients. As such, this chronic volume overload may account for 
the prevalence of hypertension and increased cardiovascular death rate in this group of pa-
tients   [33] .
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